• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Community-Scale Surveillance of SARS-CoV-2 and Influenza A Viruses in Wild Mammals, United States, 2022-2023

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2025 Aug;31(8):1625-1629.
doi: 10.3201/eid3108.241671.
Community-Scale Surveillance of SARS-CoV-2 and Influenza A Viruses in Wild Mammals, United States, 2022-2023

Grete Wilson-Henjum, J Jeffrey Root, Alex Worgo, Jeffrey Chandler, Robin Dyer, Jeff Flores, Jesse Morris, Ian Plummer, John Paul Seman, Kyle Van Why, Caleb Wellman, H Bryant White, John Wilt, Diego Diel, Jon Heale, David L Bergman, Josh Hewitt, Derek Collins, Ryan S Miller, Steven Rekant, Kim M Pepin
Abstract

Sampling of mammal communities across the United States during 2022-2023 detected evidence of SARS-CoV-2 antibodies in 3 new species and 2 previously described species and evidence of influenza A antibodies in 2 previously described species. Our analysis provides surveillance and sampling guidance for detection of rare exposure events.

Keywords: SARS-CoV-2; United States; detection; influenza; influenza A; respiratory infections; surveillance; viruses; wildlife community; zoonoses.

 
Back
Top Bottom